. 2022 Jul 8;10:909862.
doi: 10.3389/fped.2022.909862. eCollection 2022. https://pubmed.ncbi.nlm.nih.gov/35874557/
Chronic Lung Disease Following Neonatal Extracorporeal Membrane Oxygenation: A Single-Center Experience
Alba Perez Ortiz 1, Anna Glauner 1, Felix Dittgen 1, Thalia Doniga 1, Svetlana Hetjens 2, Thomas Schaible 1, Neysan Rafat 1
- PMID: 35874557
- PMCID: PMC9304759
- DOI: 10.3389/fped.2022.909862
Free PMC article
Objective: To assess the incidence and severity of chronic lung disease (CLD) after neonatal extracorporeal membrane oxygenation (ECMO) and to identify factors associated with its development.
Methods: A retrospective observational study in a neonatal ECMO center was conducted. All neonates who received support with ECMO in our institution between January 2019 and October 2021 were included and their pulmonary outcome was investigated.
Results: A total of 91 patients [60 with congenital diaphragmatic hernia (CDH), 26 with meconium aspiration syndrome, and 5 with other diagnoses] were included in this study. Sixty-eight (75%) neonates survived. Fifty-two (76%) ECMO survivors developed CLD. There was no statistical difference between patients with and without CLD with regard to gender or gestational age. Patients with CLD had lower birth weight, were younger at the initiation of ECMO, and required longer ECMO runs. Patients with CDH developed CLD more often than infants with other underlying diseases (94 vs. 60%). Seventeen ECMO survivors (25%) developed severe CLD.
Conclusion: The incidence of CLD after neonatal ECMO is substantial. Risk factors for its development include CDH as an underlying condition, the necessity for early initiation of ECMO, and the need for ECMO over 7 days.
Keywords: chronic lung disease; congenital diaphragmatic hernia; extracorporeal membrane oxygenation; neonatal lung disease; respiratory failure.
Copyright © 2022 Perez Ortiz, Glauner, Dittgen, Doniga, Hetjens, Schaible and Rafat.